- 公司资讯
- finviz | 2022年09月23日 18:50NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference
- finviz | 2022年09月23日 04:05NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
- finviz | 2022年09月16日 20:35Life Sciences Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
- finviz | 2022年09月13日 18:50NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum
- finviz | 2022年09月12日 20:35Life Sciences Virtual Investor Conference Agenda Announced for September 15th
- finviz | 2022年09月12日 18:50NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctors Eczema Balm on Return QVC
- finviz | 2022年09月09日 20:00NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million
- finviz | 2022年08月12日 04:30Edited Transcript of NBY.A earnings conference call or presentation 11-Aug-22 8:30pm GMT
- finviz | 2022年08月12日 04:05NovaBay Pharmaceuticals Reports Second Quarter 2022 Financial Results
- finviz | 2022年08月04日 18:50NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11
- finviz | 2022年07月28日 18:50NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova
- finviz | 2022年07月21日 18:50NovaBay Pharmaceuticals DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com
- finviz | 2022年07月15日 18:50NovaBay Pharmaceuticals Reports Record Avenova
- finviz | 2022年07月07日 18:50NovaBay Pharmaceuticals DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America
- finviz | 2022年05月13日 04:05NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results
- finviz | 2022年05月09日 18:50NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations
首页
上页
下页